ArticleBritish journal of pharmacology2017

Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis.

Theerut Luangmonkong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.